SEARCH

SEARCH BY CITATION

References

  • 1
    Bueno L, Fioramonti J, Delvaux M, Frexinos J. Mediators and pharmacology of visceral hypersensitivity: from basic to clinical investigations. Gastroenterology 1997; 112(5): 171443.
  • 2
    Bouin M, Plourde V, Boivin M, et al. Rectal distension testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology 2002; 122(7): 17717.
  • 3
    Mertz H. Role of the brain and sensory pathways in gastrointestinal sensory disorders in humans. Gut 2002; 51(Suppl. 1): i2933.
  • 4
    Mayer EA, Munakata J, Mertz H, Lembo T, Bernstein CN. Visceral hyperalgesia and the irritable bowel syndrome. In: GebhartGF, ed. Visceral Pain. Progress in Pain Research and Management, Vol. 2. Seattle: IASP Press, 1995: 42968.
  • 5
    Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995; 109(1): 4052.
  • 6
    Munakata J, Naliboff B, Harraf F, et al. Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome. Gastroenterology 1997; 112(1): 5563.
  • 7
    Chang L, Munakata J, Mayer EA, et al. Perceptual responses in patients with inflammatory and functional bowel disease. Gut 2000; 47(4): 497505.
  • 8
    Binimelis J, Webb SM, Mones J. Somatostatin and irritable bowel syndrome. Lancet 1987; 2(8574): 1533.
  • 9
    Talley NJ, Turner I, Middleton WR. Somatostatin and symptomatic relief of irritable bowel syndrome. Lancet 1987; 2: 1144.
  • 10
    Humphrey P. Somatostatin receptor activation and analgesia. In: SandlerM, FerrariM, HarnettS, eds. Migraine. Pharmacology and Genetics. London: Chapman & Hall, 1996: 22232.
  • 11
    McKeen ES, Feniuk W, Humphrey PP. Somatostatin receptors mediating inhibition of basal and stimulated electrogenic ion transport in rat isolated distal colonic mucosa. Naunyn Schmiedebergs Arch Pharmacol 1995; 352(4): 40211.
  • 12
    Su W, Burton MB, Gebhart GF. Effects of octreotide on responses to noxious colorectal distension in the rat. Gut 2001; 48(5): 67682.
  • 13
    Plourde V, Lembo T, Shui Z, et al. Effects of the somatostatin analogue octreotide on rectal afferent nerves in humans. Am J Physiol Gastrointest Liver Physiol 1993; 265: G74251.
  • 14
    Hasler WL, Soudah HC, Owyang C. A somatostatin analogue inhibits afferent pathways mediating perception of rectal distension. Gastroenterology 1993; 104(5): 13907.
  • 15
    Hasler WL, Soudah HC, Owyang C. Somatostatin analog inhibits afferent response to rectal distension in diarrhea-predominant irritable bowel patients. J Pharmacol Exp Ther 1994; 268(3): 120611.
  • 16
    Bradette M, Delvaux M, Staumont G, et al. Octreotide increases thresholds of colonic visceral perception in IBS patients without modifying muscle tone. Dig Dis Sci 1994; 39(6): 11718.
  • 17
    Mertz H, Walsh JH, Sytnik B, Mayer EA. The effect of octreotide on human gastric compliance and sensory perception. Neurogastroenterol Motil 1995; 7: 17585.
  • 18
    Chey WD, Beydoun A, Roberts DJ, Hasler WL, Owyang C. Octreotide reduces perception of rectal electrical stimulation by spinal afferent pathway inhibition. Am J Physiol Gastrointest Liver Physiol 1995; 269(6 Part 1): G8216.
  • 19
    Naliboff BD, Munakata J, Fullerton S, et al. Evidence for two distinct perceptual alterations in irritable bowel syndrome. Gut 1997; 41: 50512.
  • 20
    Gracely RH. Pain psychophysics. In: ChapmanCR, LoeserJD, eds. Advances in Pain Research and Therapy: Issues in Pain Measurement. New York: Raven Press, 1995: 21129.
  • 21
    Thompson WG, Creed F, Drossman DA, Heaton KW, Mazzacca G. Functional bowel disease and functional abdominal pain. Gastroenterol Int 1992; 5: 7591.
  • 22
    Chang L, Naliboff BD, Schmulson M, et al. The role of gender and bowel habit predominance on visceral perception in IBS. Gastroenterology 2001; 120: A755(Abstract).
  • 23
    Gracely RH, McGrath P, Dubner R. Ratio scales of sensory and affective verbal pain descriptors. Pain 1978; 5(1): 518.
  • 24
    Derogatis LR. SCL-90R. Administration, Scoring and Procedures Manual — II. Towson, MD: NCS, Inc., 1983.
  • 25
    Lembo T, Munakata J, Mertz H, et al. Evidence for the hypersensitivity of lumbar splanchnic afferents in irritable bowel syndrome. Gastroenterology 1994; 107(6): 168696.
  • 26
    Lembo T, Naliboff BD, Matin K, et al. Irritable bowel syndrome patients show altered sensitivity to exogenous opioids. Pain 2000; 87(2): 13747.
  • 27
    Whitehead WE, Crowell MD, Shone D, et al. Sensitivity to rectal distension: validation of a measurement system. Gastroenterology 1993; 104: A600(Abstract).
  • 28
    Kirk RE. Experimental Design: Procedures for the Behavioral Sciences. Monterey, CA: Brooks/Cole Publishing Co, 1982.
  • 29
    Tuchscherer MM, Seybold VS. A quantitative study of the coexistence of peptides in varicosities within the superficial laminae of the dorsal horn of the rat spinal cord. J Neurosci 1989; 9(1): 195205.
  • 30
    Ribeiro-da-Silva A, Cuello AC. Ultrastructural evidence for the occurrence of two distinct somatostatin-containing systems in the substantia gelatinosa of rat spinal cord. J Chem Neuroanat 1990; 3(2): 14153.
  • 31
    Schulz S, Schreff M, Schmidt H, et al. Immunocytochemical localization of somatostatin receptor sst2A in the rat spinal cord and dorsal root ganglia. Eur J Neurosci 1998; 10(12): 37008.
  • 32
    Martin JL, Chesselet MF, Raynor K, Gonzales C, Reisine T. Differential distribution of somatostatin receptor subtypes in rat brain revealed by newly developed somatostatin analogs. Neuroscience 1991; 41(2–3): 58193.
  • 33
    Uhl GR, Tran V, Snyder SH, Martin JB. Somatostatin receptors: distribution in rat central nervous system and human frontal cortex. J Comp Neurol 1985; 240(3): 288304.
  • 34
    Tran VT, Uhl GR, Perry DC, et al. Autoradiographic localization of somatostatin receptors in rat brain. Eur J Pharmacol 1984; 101(3–4): 3079.
  • 35
    Epelbaum J, Tapia Arancibia L, Kordon C, Enjalbert A. Characterization, regional distribution, and subcellular distribution of 125I-Tyr1-somatostatin binding sites in rat brain. J Neurochem 1982; 38(6): 151523.
  • 36
    Rainville P, Duncan GH, Price DD, Carrier B, Bushnell MC. Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science 1997; 277: 96871.
  • 37
    Schindler M, Sellers LA, Humphrey PP, Emson PC. Immunohistochemical localization of the somatostatin SST2 (A) receptor in the rat brain and spinal cord. Neuroscience 1997; 76(1): 22540.
  • 38
    Holloway S, Feniuk W, Kidd EJ, Humphrey PP. A quantitative autoradiographical study on the distribution of somatostatin sst2 receptors in the rat central nervous system using [125I]-BIM-23027. Neuropharmacology 1996; 35(8): 110920.
  • 39
    Naliboff BD, Derbyshire SWG, Munakata J, et al. Cerebral activation in irritable bowel syndrome patients and control subjects during rectosigmoid stimulation. Psychosom Med 2001; 63(3): 36575.
  • 40
    Mertz H, Morgan V, Tanner G, et al. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distension. Gastroenterology 2000; 118: 8428.
  • 41
    Petrovic P, Ingvar M. Imaging cognitive modulation of pain processing. Pain 2002; 95(1–2): 15.
  • 42
    Porreca F, Ossipov MH, Gebhart GF. Chronic pain and medullary descending facilitation. Trends Neurosci 2002; 25(6): 31925.
  • 43
    Lamberts SW, Van Der Lely AJ, De Herder WW, Hofland LJ. Octreotide. N Engl J Med 1996; 334(4): 24654.
  • 44
    Reisine T, Bell GI. Molecular biology of somatostatin receptors. Endocr Rev 1995; 16(4): 42742.